Y. Benhamou

4.9k total citations
123 papers, 1.8k citations indexed

About

Y. Benhamou is a scholar working on Immunology, Hematology and Surgery. According to data from OpenAlex, Y. Benhamou has authored 123 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 37 papers in Hematology and 22 papers in Surgery. Recurrent topics in Y. Benhamou's work include Complement system in diseases (29 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Platelet Disorders and Treatments (17 papers). Y. Benhamou is often cited by papers focused on Complement system in diseases (29 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Platelet Disorders and Treatments (17 papers). Y. Benhamou collaborates with scholars based in France, United States and Austria. Y. Benhamou's co-authors include H. Lévesque, Paul Coppo, Agnès Veyradier, M. Le Besnerais, S. Miranda, Lionel Galicier, Pascale Poullin, François Provôt, Aurélie Guiot and Ghassan Moubarak and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Y. Benhamou

110 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Benhamou France 22 671 458 415 348 340 123 1.8k
L. Sailler France 24 261 0.4× 697 1.5× 113 0.3× 414 1.2× 467 1.4× 135 2.0k
Françoise Boehlen Switzerland 26 322 0.5× 1.2k 2.6× 131 0.3× 470 1.4× 257 0.8× 96 2.3k
Lorenzo Cavagna Italy 28 410 0.6× 195 0.4× 286 0.7× 727 2.1× 671 2.0× 119 2.2k
R. Castillo United States 23 234 0.3× 592 1.3× 139 0.3× 93 0.3× 166 0.5× 67 1.4k
Vimal K. Derebail United States 26 122 0.2× 676 1.5× 711 1.7× 189 0.5× 401 1.2× 95 1.9k
Damien Noone Canada 20 326 0.5× 168 0.4× 849 2.0× 149 0.4× 260 0.8× 70 1.4k
C. John Sperati United States 19 411 0.6× 248 0.5× 345 0.8× 93 0.3× 308 0.9× 52 1.3k
Jan–Dirk Studt Switzerland 23 588 0.9× 583 1.3× 286 0.7× 30 0.1× 180 0.5× 65 2.8k
Paras Karmacharya United States 22 317 0.5× 193 0.4× 66 0.2× 454 1.3× 156 0.5× 81 1.3k
Denis Wahl France 36 440 0.7× 1.6k 3.5× 318 0.8× 2.3k 6.5× 340 1.0× 135 4.2k

Countries citing papers authored by Y. Benhamou

Since Specialization
Citations

This map shows the geographic impact of Y. Benhamou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Benhamou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Benhamou more than expected).

Fields of papers citing papers by Y. Benhamou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Benhamou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Benhamou. The network helps show where Y. Benhamou may publish in the future.

Co-authorship network of co-authors of Y. Benhamou

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Benhamou. A scholar is included among the top collaborators of Y. Benhamou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Benhamou. Y. Benhamou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joly, Bérangère S., Adrien Joseph, Pierre Boisseau, et al.. (2025). Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura. Blood Advances. 10(5). 1831–1842.
2.
Noël, Nicolas, Jean M. Schmidt, Achille Aouba, et al.. (2025). Comparing the efficacy and safety of cyclophosphamide, infliximab and methotrexate in neurosarcoidosis: a multicenter retrospective study. Journal of Neurology. 272(8). 531–531.
3.
Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2024). Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer ». La Revue de Médecine Interne. 45(4). 210–225. 2 indexed citations
4.
Lévesque, H., Benoît Guillet, Roseline d’Oiron, & Y. Benhamou. (2024). Hémophilie acquise : quoi de neuf en 2024 ?. La Revue de Médecine Interne. 45(11). 710–725.
5.
Prata, Pedro Henrique, Jacques‐Emmanuel Galimard, Flore Sicre de Fontbrune, et al.. (2023). Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria. Blood. 141(15). 1812–1816. 7 indexed citations
6.
Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2023). Anticoagulant treatment of cancer-associated thromboembolism. Archives of cardiovascular diseases. 117(1). 29–44. 8 indexed citations
7.
Lévesque, H., Benoît Guillet, & Y. Benhamou. (2022). Hémophilie acquise et grossesse : une approche forcément multidisciplinaire. La Revue de Médecine Interne. 43(8). 494–497. 2 indexed citations
8.
Dillinger, Jean‐Guillaume, Boris Aleil, S. Cheggour, et al.. (2017). Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases. 111(2). 85–94. 25 indexed citations
9.
Grall, Maximilien, François Provôt, Jean‐Philippe Coindre, et al.. (2016). Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre. Blood. 128(22). 136–136. 6 indexed citations
10.
11.
Besnerais, M. Le, et al.. (2016). L’érythromélalgie : approche diagnostique et thérapeutique actuelle. La Revue de Médecine Interne. 38(3). 176–180. 4 indexed citations
12.
Grall, Maximilien, S. Miranda, Nathalie Contentin, et al.. (2016). Une cause rare d’ischémie digitale. La Revue de Médecine Interne. 38(4). 282–283. 1 indexed citations
13.
Armengol, G., et al.. (2015). Icatibant in ACE-inhibitor-induced angioedema.. New England Journal of Medicine. 372(19). 1867. 8 indexed citations
14.
Armengol, G., Laurence Bouillet, Isabelle Boccon‐Gibod, et al.. (2015). Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database. Journal of Clinical Immunology. 36(1). 95–102. 20 indexed citations
15.
Ngo, Stéphanie, Y. Benhamou, G. Armengol, et al.. (2015). Agranulocytose à la fluindione : à propos d’un cas. La Revue de Médecine Interne. 37(1). 58–61.
16.
Benhamou, Y., et al.. (2015). Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis. Joint Bone Spine. 82(3). 200–202. 10 indexed citations
17.
Benhamou, Y., Stéphane Leprêtre, Edith Köning, et al.. (2014). Hématome intra-hépatique spontané : une étiologie inattendue. La Revue de Médecine Interne. 36(2). 127–130. 2 indexed citations
18.
Benhamou, Y., Julie Favre, Philippe Musette, et al.. (2009). Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice. Critical Care Medicine. 37(5). 1724–1728. 18 indexed citations
19.
Lévesque, H., Mikaël Daouphars, Véronique Le Cam‐Duchez, et al.. (2009). Facteurs de risque de surdosage en antivitamines K : une étude cas-témoins menée chez des patients non sélectionnés admis dans un service d'urgences. Journal de Pharmacie Clinique. 28(2). 73–81. 1 indexed citations
20.
Benhamou, Y. & H. Lévesque. (2006). Quelle technique utilisez-vous pour la mesure de l’index systolique ?. Sang thrombose vaisseaux. 18(5). 278–281. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Sailler Breakdown of academic impact, for papers by Françoise Boehlen Breakdown of academic impact, for papers by Lorenzo Cavagna Breakdown of academic impact, for papers by R. Castillo Breakdown of academic impact, for papers by Vimal K. Derebail Breakdown of academic impact, for papers by Damien Noone Breakdown of academic impact, for papers by C. John Sperati Breakdown of academic impact, for papers by Jan–Dirk Studt Breakdown of academic impact, for papers by Paras Karmacharya Breakdown of academic impact, for papers by Denis Wahl
Rankless by CCL
2026